tiprankstipranks
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Holding DE:52U?
Track your performance easily

Hyloris Pharmaceuticals SA (52U) Financial Statements

4 Followers

Hyloris Pharmaceuticals SA Financial Overview

Hyloris Pharmaceuticals SA's market cap is currently ―. The company's EPS TTM is €-0.436; its P/E ratio is -12.96; Hyloris Pharmaceuticals SA is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Jun 20Mar 20
Income Statement-
Total Revenue---€ 19.00K€ 63.00K
Gross Profit---€ -70.00K€ 43.00K
EBIT---€ -1.69M€ -1.35M
EBITDA---€ -1.66M€ -1.32M
Net Income Common Stockholders---€ -2.16M€ -1.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 58.00M€ 50.54M€ 53.48M€ 66.79M€ 14.44M
Total Assets€ 72.97M€ 63.44M€ 63.98M€ 71.81M€ 20.49M
Total Debt€ 66.00K€ 12.29M€ 130.00K€ 8.40M€ 26.84M
Net Debt€ -57.94M€ -38.25M€ -53.35M€ -58.38M€ 12.39M
Total Liabilities€ 12.38M€ 15.39M€ 12.90M€ 12.15M€ 28.92M
Stockholders Equity€ 60.59M€ 48.06M€ 51.08M€ 59.67M€ -8.43M
Cash Flow-
Free Cash Flow---€ 2.29M€ -2.68M
Operating Cash Flow---€ 2.54M€ -2.44M
Investing Cash Flow---€ -247.00K€ -240.00K
Financing Cash Flow---€ 53.28M€ 13.69M
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

Hyloris Pharmaceuticals SA Debt to Assets

Hyloris Pharmaceuticals SA Cash Flow

Hyloris Pharmaceuticals SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis